S6 ) with addition of cytogenetic abnormalities, yielded very similar results with the difference that instead of TP53 mutations “complex karyotype” was found as a highly significant adverse factor, which may be explained by the strong interaction between the two genetic variables (Supplementary Fig.
← all excerpts
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients.
1
—
—